BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25451027)

  • 1. Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL.
    Dutta S; Ryan J; Chen TS; Kougentakis C; Letai A; Keating AE
    J Mol Biol; 2015 Mar; 427(6 Pt B):1241-1253. PubMed ID: 25451027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
    Dutta S; Gullá S; Chen TS; Fire E; Grant RA; Keating AE
    J Mol Biol; 2010 May; 398(5):747-62. PubMed ID: 20363230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
    Modi V; Sankararamakrishnan R
    J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases.
    Holinger EP; Chittenden T; Lutz RJ
    J Biol Chem; 1999 May; 274(19):13298-304. PubMed ID: 10224090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. By any means necessary: discovering a Bcl-xL specific domain.
    Deshayes KD
    J Mol Biol; 2015 Mar; 427(6 Pt B):1239-1240. PubMed ID: 25555991
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
    Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
    J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
    Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
    J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.
    Foight GW; Keating AE
    J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening.
    Dutta S; Chen TS; Keating AE
    ACS Chem Biol; 2013 Apr; 8(4):778-88. PubMed ID: 23363053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
    Raghav PK; Verma YK; Gangenahalli GU
    Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BH3 mimetics efficiently induce apoptosis in mouse basophils and mast cells.
    Reinhart R; Rohner L; Wicki S; Fux M; Kaufmann T
    Cell Death Differ; 2018 Jan; 25(1):204-216. PubMed ID: 28960207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins.
    Long J; Liu L; Nikolovska-Coleska Z; Shangary S; Yi H; Wang S; Wang S
    BMC Biotechnol; 2013 May; 13():45. PubMed ID: 23705845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphipathic tail-anchoring peptide and Bcl-2 homology domain-3 (BH3) peptides from Bcl-2 family proteins induce apoptosis through different mechanisms.
    Ko JK; Choi KH; Peng J; He F; Zhang Z; Weisleder N; Lin J; Ma J
    J Biol Chem; 2011 Mar; 286(11):9038-48. PubMed ID: 21189256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.
    Chen L; Willis SN; Wei A; Smith BJ; Fletcher JI; Hinds MG; Colman PM; Day CL; Adams JM; Huang DC
    Mol Cell; 2005 Feb; 17(3):393-403. PubMed ID: 15694340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.